These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 106264

  • 1. [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)].
    Adam O, Wolfram G, Lang PD, Zöllner N.
    MMW Munch Med Wochenschr; 1979 Mar 02; 121(9):319-22. PubMed ID: 106264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
    Wahl P, Hasslacher C, Lang PD, Vollmar J.
    Dtsch Med Wochenschr; 1978 Aug 04; 103(31):1233-7. PubMed ID: 668570
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Apr 14; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
    Grützmacher P, Scheuermann E, Lang W.
    Proc Eur Dial Transplant Assoc; 1981 Apr 14; 18():169-75. PubMed ID: 7036147
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
    Wilke H, Frahm H.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):401-5. PubMed ID: 1253701
    [Abstract] [Full Text] [Related]

  • 16. [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].
    Lageder H.
    Wien Klin Wochenschr; 1980 Feb 01; 92(3):95-101. PubMed ID: 6985560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
    Sterna R.
    Ann Acad Med Stetin; 1997 Feb 01; 43():67-77. PubMed ID: 9471924
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.